Quoin Pharmaceuticals Ltd ADR (QNRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2006 | |
| Cash Flows From Operating Activities | ||
| Net Income | -2,606 | N/A |
| Depreciation Amortization | 18 | N/A |
| Other Working Capital | 258 | N/A |
| Other Operating Activity | 355 | 0 |
| Operating Cash Flow | $-1,975 | $N/A |
| Cash Flows From Investing Activities | ||
| PPE Investments | -65 | N/A |
| Sale Of Investment | 879 | N/A |
| Investing Cash Flow | $814 | $N/A |
| Cash Flows From Financing Activities | ||
| Common Stock Issued | 1,639 | N/A |
| Financing Cash Flow | $1,639 | $N/A |
| Exchange Rate Effect | -18 | N/A |
| Beginning Cash Position | 544 | N/A |
| End Cash Position | 1,003 | N/A |
| Net Cash Flow | $459 | $N/A |
| Free Cash Flow | ||
| Operating Cash Flow | -1,975 | N/A |
| Capital Expenditure | -85 | N/A |
| Free Cash Flow | -2,060 | 0 |